BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Staging
19 results:

  • 1. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging.
    Feng KP; Fu K; Xu C; Ding C; Zhu XY; Pan B; Jia XY; Zhao J; Li C
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9991-9998. PubMed ID: 37258719
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
    Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
    BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres.
    Bissonnette JP; Sun A; Grills IS; Almahariq MF; Geiger G; Vogel W; Sonke JJ; Everitt S; Manus MM
    Lung Cancer; 2021 May; 155():136-143. PubMed ID: 33819859
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
    Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
    J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
    Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D; Littleford R; McConnachie A; McCowan C; McMeekin N; Patel M; Rauchhaus P; Ritchie L; Robertson C; Robertson J; Robles-Zurita J; Sarvesvaran J; Sewell H; Sproule M; Taylor T; Tello A; Treweek S; Vedhara K; Schembri S;
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732334
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Expression and Clinical Signification of PD-1 in Lymph Nodes of Patients with Non-small Cell lung cancer.
    Ma H; Mao G; Zhang G; Huang H
    Immunol Invest; 2017 Oct; 46(7):639-646. PubMed ID: 28799818
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Morphoproteomic Characterization of lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness.
    Casanova R; Xia D; Rulle U; Nanni P; Grossmann J; Vrugt B; Wettstein R; Ballester-Ripoll R; Astolfo A; Weder W; Moch H; Stampanoni M; Beck AH; Soltermann A
    Cancer Res; 2017 May; 77(10):2585-2593. PubMed ID: 28364001
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.
    Madsen PH; Holdgaard PC; Christensen JB; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2084-97. PubMed ID: 27164899
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Real-time prediction of mediastinal lymph node malignancy by endobronchial ultrasound.
    Shafiek H; Fiorentino F; Peralta AD; Serra E; Esteban B; Martinez R; Noguera MA; Moyano P; Sala E; Sauleda J; Cosío BG
    Arch Bronconeumol; 2014 Jun; 50(6):228-34. PubMed ID: 24512940
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
    Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
    Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.
    Hofman V; Bonnetaud C; Ilie MI; Vielh P; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Hofman P
    Clin Cancer Res; 2011 Feb; 17(4):827-35. PubMed ID: 21098695
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
    Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
    Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.
    Massard G; Ducrocq X; Kochetkova EA; Porhanov VA; Riquet M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):164-7. PubMed ID: 16725340
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Computer technology in detection and staging of prostate carcinoma: a review.
    Zhu Y; Williams S; Zwiggelaar R
    Med Image Anal; 2006 Apr; 10(2):178-99. PubMed ID: 16150630
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. staging small cell lung cancer: Veterans Administration lung Study Group versus International Association for the Study of lung cancer--what limits limited disease?
    Micke P; Faldum A; Metz T; Beeh KM; Bittinger F; Hengstler JG; Buhl R
    Lung Cancer; 2002 Sep; 37(3):271-6. PubMed ID: 12234695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?
    Lassen UN; Hirsch FR; Osterlind K; Bergman B; Dombernowsky P
    Lung Cancer; 1998 Jun; 20(3):151-60. PubMed ID: 9733049
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Characteristics of non-small cell lung cancer 3 cm or less in diameter.
    Tateishi M; Fukuyama Y; Hamatake M; Kohdono S; Mitsudomi T; Ishida T; Sugimachi K
    J Surg Oncol; 1995 Aug; 59(4):251-4. PubMed ID: 7630173
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.